Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer

Livia Lamartina(Laboratoire d'études sur les monothéismes), Sophie Leboulleux(Laboratoire d'études sur les monothéismes)
The Journal of Clinical Endocrinology & Metabolism
April 15, 2016
Cited by 45


Related Papers